Skip to main content
SpringerLink
Log in

Diacerein-containing products: same risk of diarrhoea?

  • Letter to the Editor
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bruyere O, Cooper C, Al-Daghri NM et al (2017) Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res. https://doi.org/10.1007/s40520-017-0861-1

    Google Scholar 

  2. Pavelka K, Bruyere O, Cooper C et al (2016) Diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs Aging 33:75–85. https://doi.org/10.1007/s40266-016-0347-4 (Erratum in: (2017) Drugs Aging 34:413. https://doi.org/10.1007/s40266-017-0457-7)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Rintelen B, Neumann K, Leeb BF (2006) A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med 166:1899–1906. https://doi.org/10.1001/archinte.166.17.1899

    Article  CAS  PubMed  Google Scholar 

  4. Bruneton J (1999) Quinones. In: Pharmacognosie: phytochimie. Plantes médicinales, 3rd edn. Tec & Doc, Paris, pp 409–445

    Google Scholar 

  5. Shanmugam S (2015) Granulation techniques and technologies: recent progresses. Bioimpacts 5:55–63. https://doi.org/10.15171/bi.2015.04

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kumar V, Tewari D (2005) Dissolution. In: Troy DB (ed) Remington: the science and practice of pharmacy, 21st edn. Lippincott Williams & Wilkins, Philadelphia, pp 672–688

    Google Scholar 

  7. Cardoso CRL, Leite NC, Carlos FO et al (2017) Efficacy and safety of diacerein in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Care 40:1356–1363. https://doi.org/10.2337/dc17-0374

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), through its Scientific Advisory Board, contributed to the literature search, critically reviewed the manuscript, and partially funded Dr Sabine Collaud Basset, who provided medical writing support.

Author information

Authors and Affiliations

  1. Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), 900 Saint-Denis, R11.412, Montreal, QC, H2X 0A9, Canada

    Jean-Pierre Pelletier & Johanne Martel-Pelletier

Authors
  1. Jean-Pierre Pelletier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johanne Martel-Pelletier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Pierre Pelletier.

Ethics declarations

Conflict of interest

Professor Jean-Pierre Pelletier is a shareholder in ArthroLab Inc. and received grants, consulting and lecture fees from TRB Chemedica. He also served as expert witness for the review of diacerein-containing medicines by the European Medicine Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC). Professor Johanne Martel-Pelletier is a shareholder in ArthroLab Inc., and received grants, consulting, and lecture fees from TRB Chemedica. She also served as expert witness for the review of diacerein-containing medicines by the European Medicine Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC).

Research involving human participants and/or animals

None.

Informed consent

None.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 22 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pelletier, JP., Martel-Pelletier, J. Diacerein-containing products: same risk of diarrhoea?. Aging Clin Exp Res 30, 411–412 (2018). https://doi.org/10.1007/s40520-018-0911-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-018-0911-3

Search

Navigation